Free Trial

Xometry (XMTR) Financials

Xometry logo
$24.86 +1.06 (+4.45%)
As of 04:00 PM Eastern
Annual Income Statements for Xometry

Annual Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-31 -40 -61 -79 -67 -50
Consolidated Net Income / (Loss)
-31 -31 -61 -79 -67 -50
Net Income / (Loss) Continuing Operations
-31 -31 -61 -79 -67 -50
Total Pre-Tax Income
-31 -31 -61 -79 -68 -50
Total Operating Income
-31 -29 -59 -77 -74 -56
Total Gross Profit
15 33 57 146 178 216
Total Revenue
80 141 218 381 463 546
Operating Revenue
80 141 218 381 463 546
Total Cost of Revenue
65 108 161 235 285 330
Operating Cost of Revenue
65 108 161 235 285 330
Total Operating Expenses
45 63 116 223 252 272
Selling, General & Admin Expense
8.02 12 35 58 71 65
Marketing Expense
15 23 39 84 94 108
Research & Development Expense
11 12 18 31 34 39
Other Operating Expenses / (Income)
10 14 24 49 52 59
Impairment Charge
1.72 1.59 0.00 0.82 0.40 0.08
Total Other Income / (Expense), net
-0.45 -1.87 -2.70 -1.92 5.76 5.73
Interest Expense
0.24 1.09 0.85 4.42 4.78 4.75
Interest & Investment Income
0.00 0.00 1.02 4.69 12 11
Other Income / (Expense), net
-0.20 -0.78 -2.87 -2.18 -1.51 -0.76
Income Tax Expense
- 0.00 0.00 0.04 -0.35 -0.02
Preferred Stock Dividends Declared
0.00 8.80 0.00 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 -0.00 0.02 0.01 -0.00
Basic Earnings per Share
($4.88) ($5.32) ($4.66) ($3.36) ($2.82) ($2.06)
Weighted Average Basic Shares Outstanding
6.35M 7.49M 52.64M 94.32M 95.83M 98.17M
Diluted Earnings per Share
($4.88) ($5.32) ($4.66) ($3.36) ($2.82) ($2.06)
Weighted Average Diluted Shares Outstanding
6.35M 7.49M 52.64M 94.32M 95.83M 98.17M
Weighted Average Basic & Diluted Shares Outstanding
6.35M 7.49M 26.32M 45.07M 48.58M 50.30M

Quarterly Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.89
Consolidated Net Income / (Loss)
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.90
Net Income / (Loss) Continuing Operations
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.90
Total Pre-Tax Income
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.94
Total Operating Income
-15 -27 -20 -28 -13 -13 -18 -15 -11 -12
Total Gross Profit
41 34 39 44 46 49 48 53 56 59
Total Revenue
104 98 105 111 119 128 123 133 142 149
Operating Revenue
104 98 105 111 119 128 123 133 142 149
Total Cost of Revenue
63 64 66 67 73 79 75 80 86 90
Operating Cost of Revenue
63 64 66 67 73 79 75 80 86 90
Total Operating Expenses
56 62 59 72 59 62 66 68 67 71
Selling, General & Admin Expense
15 15 16 26 15 14 15 16 16 17
Marketing Expense
21 26 22 23 23 25 27 27 27 27
Research & Development Expense
7.61 8.31 8.13 8.92 8.52 8.89 9.59 10 9.34 10
Other Operating Expenses / (Income)
12 12 13 14 13 13 14 14 15 16
Impairment Charge
0.33 0.38 0.03 0.22 0.15 - 0.00 0.00 0.00 0.08
Total Other Income / (Expense), net
0.16 0.48 1.58 1.43 1.33 1.43 1.25 1.58 1.31 1.59
Interest Expense
1.19 1.25 1.20 1.19 1.21 1.19 1.19 1.19 1.19 1.19
Interest & Investment Income
1.64 2.21 2.76 3.20 3.13 2.97 2.83 3.00 2.94 2.47
Other Income / (Expense), net
-0.29 -0.45 0.02 -0.58 -0.60 -0.36 -0.39 -0.23 -0.44 0.31
Income Tax Expense
0.00 0.60 0.14 -0.07 0.14 -0.56 0.00 -0.01 0.03 -0.04
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.00 -0.00 0.00 -0.01 0.01 -0.00 0.01 -0.01 0.00 -0.01
Basic Earnings per Share
($0.32) ($2.26) ($0.38) ($0.55) ($0.25) ($1.64) ($0.34) ($0.28) ($0.21) ($1.23)
Weighted Average Basic Shares Outstanding
47.30M 94.32M 47.70M 47.87M 47.99M 95.83M 48.58M 48.84M 49.28M 98.17M
Diluted Earnings per Share
($0.32) ($2.26) ($0.38) ($0.55) ($0.25) ($1.64) ($0.34) ($0.28) ($0.21) ($1.23)
Weighted Average Diluted Shares Outstanding
47.30M 94.32M 47.70M 47.87M 47.99M 95.83M 48.58M 48.84M 49.28M 98.17M
Weighted Average Basic & Diluted Shares Outstanding
44.76M 45.07M 45.17M 45.29M 45.39M 48.58M 46.12M 49.30M 49.56M 50.30M

Annual Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
25 20 26 -21 -12 -31
Net Cash From Operating Activities
-27 -22 -69 -63 -30 -15
Net Cash From Continuing Operating Activities
-27 -22 -69 -63 -30 -15
Net Income / (Loss) Continuing Operations
-31 -31 -61 -79 -67 -50
Consolidated Net Income / (Loss)
-31 -31 -61 -79 -67 -50
Depreciation Expense
1.85 3.12 3.60 7.82 11 13
Amortization Expense
-0.04 0.00 0.00 1.72 1.86 1.86
Non-Cash Adjustments To Reconcile Net Income
3.54 3.95 13 33 38 36
Changes in Operating Assets and Liabilities, net
-1.48 1.97 -24 -26 -13 -15
Net Cash From Investing Activities
-2.35 6.67 -213 -239 17 -20
Net Cash From Continuing Investing Activities
-2.35 6.67 -213 -239 17 -20
Purchase of Property, Plant & Equipment
-2.69 -4.19 -6.26 -14 -18 -18
Acquisitions
-1.43 0.00 -175 0.00 -3.35 0.00
Purchase of Investments
-29 -18 -267 -284 -12 -19
Sale of Property, Plant & Equipment
0.16 0.00 0.00 0.19 0.22 0.08
Sale and/or Maturity of Investments
30 29 235 59 50 17
Other Investing Activities, net
0.00 0.00 0.63 0.00 0.00 0.00
Net Cash From Financing Activities
55 35 308 281 1.07 4.64
Net Cash From Continuing Financing Activities
55 35 308 281 1.07 4.64
Repayment of Debt
-0.50 -4.78 -16 -9.31 0.00 0.00
Repurchase of Preferred Equity
0.00 -13 0.00 0.00 0.00 0.00
Repurchase of Common Equity
0.00 0.00 -3.68 0.00 0.00 0.00
Payment of Dividends
0.00 -8.80 0.00 0.00 0.00 0.00
Issuance of Debt
0.00 8.78 0.00 288 0.00 0.00
Issuance of Preferred Equity
55 52 0.00 0.00 0.00 0.00
Issuance of Common Equity
0.00 0.00 325 0.00 0.00 0.00
Other Financing Activities, net
0.29 0.51 2.32 2.78 1.07 4.64
Effect of Exchange Rate Changes
- -0.13 -0.06 -0.37 -0.23 -0.27
Cash Interest Paid
1.11 1.27 0.91 1.41 2.88 2.88

Quarterly Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-16 35 -26 17 -12 9.05 -7.72 -24 -4.64 4.80
Net Cash From Operating Activities
-11 -17 -16 -6.15 -5.98 -1.29 -12 -9.10 -3.63 9.09
Net Cash From Continuing Operating Activities
-11 -17 -16 -6.32 -5.81 -1.29 -12 -9.10 -3.63 9.09
Net Income / (Loss) Continuing Operations
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.90
Consolidated Net Income / (Loss)
-15 -27 -18 -27 -12 -11 -17 -14 -10 -9.90
Depreciation Expense
1.91 2.10 2.57 2.90 2.48 2.80 3.15 3.26 3.21 3.39
Amortization Expense
0.47 0.47 0.47 13 -12 0.46 0.46 0.47 0.46 0.47
Non-Cash Adjustments To Reconcile Net Income
8.71 10 7.05 3.96 20 7.42 7.38 9.58 8.44 10
Changes in Operating Assets and Liabilities, net
-7.36 -2.21 -8.20 0.74 -4.31 -1.42 -6.13 -8.70 -5.55 5.01
Net Cash From Investing Activities
-5.51 53 -10 23 -6.56 11 2.93 -15 -2.59 -5.45
Net Cash From Continuing Investing Activities
-5.51 53 -10 23 -6.56 11 2.93 -15 -2.59 -5.45
Purchase of Property, Plant & Equipment
-4.17 -4.04 -4.19 -4.31 -3.57 -6.42 -4.35 -4.40 -4.81 -4.54
Purchase of Investments
-1.34 -2.20 -2.69 -2.95 -2.99 -2.95 -2.73 -11 -2.77 -2.50
Sale and/or Maturity of Investments
- 59 0.00 30 - 20 10 0.01 4.99 1.59
Net Cash From Financing Activities
0.85 -0.53 0.48 0.66 0.28 -0.36 1.23 0.56 1.42 1.42
Net Cash From Continuing Financing Activities
0.85 -0.53 0.48 0.66 0.28 -0.36 1.23 0.56 1.42 1.42
Other Financing Activities, net
0.85 -0.53 0.48 0.66 0.28 -0.36 1.23 0.56 1.42 1.42
Effect of Exchange Rate Changes
-0.36 0.06 0.02 -0.22 -0.11 0.08 -0.15 -0.02 0.17 -0.26

Annual Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets
89 503 734 707 680
Total Current Assets
78 163 387 356 328
Cash & Equivalents
60 86 66 53 22
Short-Term Investments
0.00 30 254 215 218
Accounts Receivable
15 32 49 70 74
Inventories, net
2.29 2.03 1.57 2.89 3.92
Prepaid Expenses
0.91 6.66 7.59 5.57 4.95
Other Current Assets
0.00 5.58 9.37 8.90 4.87
Plant, Property, & Equipment, net
6.11 10 19 36 45
Total Noncurrent Assets
5.20 329 328 316 308
Long-Term Investments
0.00 4.20 4.07 4.11 4.07
Goodwill
0.83 255 258 263 263
Intangible Assets
1.65 42 39 36 32
Other Noncurrent Operating Assets
2.71 28 26 13 8.87
Total Liabilities & Shareholders' Equity
89 503 734 707 680
Total Liabilities
39 77 362 377 365
Total Current Liabilities
38 57 64 83 75
Accounts Payable
5.64 13 12 44 35
Accrued Expenses
14 31 33 23 24
Current Deferred & Payable Income Tax Liabilities
- 0.00 3.96 2.48 0.98
Other Current Liabilities
3.38 5.55 5.47 14 14
Total Noncurrent Liabilities
1.12 20 298 294 290
Long-Term Debt
- 0.00 280 282 284
Noncurrent Deferred Revenue
0.00 1.45 0.00 0.00 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.02 0.43 0.28 0.23
Other Noncurrent Operating Liabilities
1.12 19 18 12 5.89
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-111 425 372 330 316
Total Preferred & Common Equity
-111 424 371 329 314
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
-111 424 371 329 314
Common Stock
0.50 598 623 648 685
Retained Earnings
-112 -173 -252 -320 -370
Accumulated Other Comprehensive Income / (Loss)
0.21 0.15 0.03 0.86 -0.33
Noncontrolling Interest
0.00 1.03 1.09 1.12 1.14

Quarterly Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
754 725 708 701 692 679 678
Total Current Assets
410 373 365 357 341 327 326
Cash & Equivalents
30 40 57 44 46 22 17
Short-Term Investments
311 256 229 232 208 219 217
Accounts Receivable
51 52 58 64 69 71 79
Inventories, net
5.63 1.44 1.34 1.31 2.89 2.87 3.50
Prepaid Expenses
7.68 7.06 5.83 4.90 6.00 6.06 4.79
Other Current Assets
4.36 16 14 10 9.37 6.51 4.86
Plant, Property, & Equipment, net
16 22 24 26 38 40 42
Total Noncurrent Assets
328 330 320 318 314 312 310
Long-Term Investments
4.30 4.13 4.27 4.21 4.21 4.14 4.21
Goodwill
260 262 263 263 263 263 263
Intangible Assets
40 39 38 37 35 34 33
Other Noncurrent Operating Assets
24 25 15 14 12 11 9.98
Total Liabilities & Shareholders' Equity
754 725 708 701 692 679 678
Total Liabilities
361 362 366 364 371 362 362
Total Current Liabilities
65 65 69 68 79 71 71
Accounts Payable
12 12 13 13 14 10 6.37
Accrued Expenses
36 32 37 35 46 43 49
Current Deferred Revenue
11 9.97 10.00 9.66 9.61 9.05 8.30
Current Deferred & Payable Income Tax Liabilities
- 4.11 2.80 2.96 2.21 1.33 0.86
Other Current Liabilities
5.90 6.26 6.50 6.74 6.73 6.66 6.64
Total Noncurrent Liabilities
296 298 297 296 292 291 291
Long-Term Debt
279 280 281 281 282 283 283
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.41 0.39 0.36 0.28 0.26 0.25
Other Noncurrent Operating Liabilities
15 17 16 14 9.63 8.17 7.55
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
393 362 342 337 322 317 316
Total Preferred & Common Equity
392 361 341 336 320 316 315
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
392 361 341 336 320 316 315
Common Stock
617 629 635 642 657 666 674
Retained Earnings
-225 -268 -294 -306 -336 -350 -360
Accumulated Other Comprehensive Income / (Loss)
-0.49 0.16 0.36 0.44 0.38 0.46 1.28
Noncontrolling Interest
1.12 1.10 1.11 1.14 1.15 1.15 1.13

Annual Metrics and Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - -
Revenue Growth
0.00% 76.26% 54.40% 74.47% 21.65% 17.72%
EBITDA Growth
0.00% 7.14% -115.64% -20.33% 10.39% 32.73%
EBIT Growth
0.00% 2.46% -105.20% -28.79% 5.28% 24.21%
NOPAT Growth
0.00% 4.36% -100.87% -31.36% 4.56% 23.69%
Net Income Growth
0.00% -0.29% -97.46% -28.77% 14.65% 25.29%
EPS Growth
0.00% -9.02% 12.41% 27.90% 16.07% 26.95%
Operating Cash Flow Growth
0.00% 18.71% -210.99% 8.74% 52.25% 48.51%
Free Cash Flow Firm Growth
0.00% 0.00% -1,219.27% 77.19% 19.35% 11.60%
Invested Capital Growth
0.00% 0.00% 5,600.13% 7.77% 3.38% 4.72%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 8.85% 6.94% 3.89%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -3.09% 19.96% 5.13%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -4.44% 16.55% 2.87%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -6.59% 16.75% 1.78%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -4.71% 20.04% 1.29%
EPS Q/Q Growth
0.00% 0.00% 0.00% -27.27% 18.02% 16.60%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -62.21% 18.43% 34.55% 40.29%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 13.27% 13.65%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.40% 0.62% -1.65%
Profitability Metrics
- - - - - -
Gross Margin
18.37% 23.54% 26.17% 38.33% 38.47% 39.53%
EBITDA Margin
-36.08% -19.01% -26.54% -18.31% -13.48% -7.71%
Operating Margin
-38.08% -20.66% -26.88% -20.24% -15.88% -10.29%
EBIT Margin
-38.33% -21.21% -28.19% -20.81% -16.20% -10.43%
Profit (Net Income) Margin
-38.63% -21.98% -28.11% -20.75% -14.56% -9.24%
Tax Burden Percent
100.00% 100.00% 100.00% 100.05% 99.48% 99.96%
Interest Burden Percent
100.78% 103.63% 99.72% 99.66% 90.32% 88.61%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -765.53% -26.51% -17.06% -15.43% -11.32%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -717.33% -1.91% 13.43% 76.54% -56.98%
Return on Net Nonoperating Assets (RNNOA)
0.00% 639.85% 0.66% -2.77% -3.78% -4.29%
Return on Equity (ROE)
0.00% -125.69% -25.85% -19.83% -19.21% -15.60%
Cash Return on Invested Capital (CROIC)
0.00% -965.53% -219.62% -24.53% -18.75% -15.93%
Operating Return on Assets (OROA)
0.00% -33.72% -20.81% -12.82% -10.42% -8.20%
Return on Assets (ROA)
0.00% -34.94% -20.75% -12.78% -9.36% -7.27%
Return on Common Equity (ROCE)
0.00% 282.68% -17.04% -19.78% -19.15% -15.55%
Return on Equity Simple (ROE_SIMPLE)
0.00% 27.94% -14.46% -21.32% -20.49% -16.03%
Net Operating Profit after Tax (NOPAT)
-21 -20 -41 -54 -52 -39
NOPAT Margin
-26.65% -14.46% -18.82% -14.17% -11.11% -7.20%
Net Nonoperating Expense Percent (NNEP)
0.00% -48.20% -24.60% -30.49% -91.97% 45.67%
Return On Investment Capital (ROIC_SIMPLE)
- - - -8.28% -8.41% -6.56%
Cost of Revenue to Revenue
81.63% 76.46% 73.83% 61.67% 61.53% 60.47%
SG&A Expenses to Revenue
9.99% 8.52% 16.00% 15.29% 15.30% 11.91%
R&D to Revenue
13.26% 8.62% 8.14% 8.14% 7.44% 7.21%
Operating Expenses to Revenue
56.45% 44.20% 53.05% 58.56% 54.34% 49.82%
Earnings before Interest and Taxes (EBIT)
-31 -30 -62 -79 -75 -57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-29 -27 -58 -70 -62 -42
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 5.04 3.89 4.95 6.72
Price to Tangible Book Value (P/TBV)
0.00 0.00 16.71 19.68 53.24 107.72
Price to Revenue (P/Rev)
3.77 2.14 9.80 3.79 3.52 3.88
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 78.44 6.63 4.27 4.83 6.07
Enterprise Value to Revenue (EV/Rev)
0.00 2.96 9.25 3.68 3.54 3.95
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.32 0.00 0.75 0.85 0.90
Long-Term Debt to Equity
0.00 0.00 0.00 0.75 0.85 0.90
Financial Leverage
0.00 -0.89 -0.35 -0.21 -0.05 0.08
Leverage Ratio
0.00 1.80 1.25 1.55 2.05 2.15
Compound Leverage Factor
0.00 1.86 1.24 1.55 1.85 1.90
Debt to Total Capital
0.00% 24.15% 0.00% 42.95% 46.03% 47.33%
Short-Term Debt to Total Capital
0.00% 24.15% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 42.95% 46.03% 47.33%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 246.43% 0.24% 0.17% 0.18% 0.19%
Common Equity to Total Capital
0.00% -170.58% 99.76% 56.88% 53.79% 52.48%
Debt to EBITDA
0.00 -0.59 0.00 -4.01 -4.51 -6.75
Net Debt to EBITDA
0.00 1.64 0.00 0.63 -0.14 -0.95
Long-Term Debt to EBITDA
0.00 0.00 0.00 -4.01 -4.51 -6.75
Debt to NOPAT
0.00 -0.77 0.00 -5.19 -5.47 -7.22
Net Debt to NOPAT
0.00 2.16 0.00 0.81 -0.17 -1.01
Long-Term Debt to NOPAT
0.00 0.00 0.00 -5.19 -5.47 -7.22
Altman Z-Score
0.00 3.84 16.45 2.60 2.73 3.69
Noncontrolling Interest Sharing Ratio
0.00% 324.91% 34.06% 0.27% 0.31% 0.35%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 2.02 2.87 6.05 4.28 4.38
Quick Ratio
0.00 1.94 2.62 5.76 4.07 4.20
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -26 -340 -78 -63 -55
Operating Cash Flow to CapEx
-1,068.75% -526.23% -1,095.03% -464.86% -163.59% -85.38%
Free Cash Flow to Firm to Interest Expense
0.00 -23.69 -399.41 -17.57 -13.08 -11.64
Operating Cash Flow to Interest Expense
-112.55 -20.25 -80.48 -14.16 -6.25 -3.24
Operating Cash Flow Less CapEx to Interest Expense
-123.08 -24.09 -87.83 -17.21 -10.06 -7.03
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 1.59 0.74 0.62 0.64 0.79
Accounts Receivable Turnover
0.00 9.70 9.29 9.32 7.76 7.57
Inventory Turnover
0.00 47.13 74.51 130.37 127.98 97.03
Fixed Asset Turnover
0.00 23.13 26.63 25.94 16.94 13.56
Accounts Payable Turnover
0.00 19.17 17.56 18.68 10.13 8.36
Days Sales Outstanding (DSO)
0.00 37.62 39.29 39.14 47.01 48.19
Days Inventory Outstanding (DIO)
0.00 7.74 4.90 2.80 2.85 3.76
Days Payable Outstanding (DPO)
0.00 19.04 20.78 19.54 36.04 43.65
Cash Conversion Cycle (CCC)
0.00 26.32 23.40 22.40 13.82 8.31
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 5.34 305 328 339 355
Invested Capital Turnover
0.00 52.93 1.41 1.20 1.39 1.57
Increase / (Decrease) in Invested Capital
0.00 5.34 299 24 11 16
Enterprise Value (EV)
0.00 419 2,020 1,400 1,640 2,155
Market Capitalization
303 303 2,139 1,443 1,630 2,114
Book Value per Share
$0.00 ($14.85) $10.17 $8.28 $7.25 $6.34
Tangible Book Value per Share
$0.00 ($15.18) $3.07 $1.64 $0.67 $0.40
Total Capital
0.00 65 425 652 612 599
Total Debt
0.00 16 0.00 280 282 284
Total Long-Term Debt
0.00 0.00 0.00 280 282 284
Net Debt
0.00 -44 -121 -44 8.88 40
Capital Expenditures (CapEx)
2.54 4.19 6.26 13 18 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -4.85 -10 3.79 4.26 13
Debt-free Net Working Capital (DFNWC)
0.00 55 106 323 273 253
Net Working Capital (NWC)
0.00 39 106 323 273 253
Net Nonoperating Expense (NNE)
9.61 11 20 25 16 11
Net Nonoperating Obligations (NNO)
0.00 -44 -121 -44 8.88 40
Total Depreciation and Amortization (D&A)
1.81 3.12 3.60 9.54 13 15
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -3.43% -4.73% 0.99% 0.92% 2.37%
Debt-free Net Working Capital to Revenue
0.00% 38.91% 48.73% 84.85% 58.92% 46.33%
Net Working Capital to Revenue
0.00% 27.77% 48.73% 84.85% 58.92% 46.33%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.33) ($1.61) ($2.82) ($2.06)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 44.16M 47.16M 95.83M 98.17M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.33) ($1.61) ($2.82) ($2.06)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 44.16M 47.16M 95.83M 98.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($2.33) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 26.32M 45.07M 48.58M 50.30M
Normalized Net Operating Profit after Tax (NOPAT)
-20 -19 -41 -53 -51 -39
Normalized NOPAT Margin
-25.15% -13.67% -18.82% -14.02% -11.05% -7.19%
Pre Tax Income Margin
-38.63% -21.98% -28.11% -20.74% -14.63% -9.24%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-127.61 -27.54 -72.24 -17.94 -15.70 -11.98
NOPAT to Interest Expense
-88.73 -18.78 -48.22 -12.21 -10.77 -8.27
EBIT Less CapEx to Interest Expense
-138.14 -31.39 -79.59 -20.99 -19.51 -15.77
NOPAT Less CapEx to Interest Expense
-99.26 -22.63 -55.57 -15.26 -14.58 -12.06
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% -28.31% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -28.31% -5.99% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
82.58% 46.15% 25.88% 16.10% 14.83% 30.67% 16.49% 19.45% 19.15% 15.92%
EBITDA Growth
7.88% -9.04% 5.99% 3.79% -75.66% 61.81% 12.61% 9.86% 64.18% 23.58%
EBIT Growth
-2.92% -13.80% 0.73% -78.01% 10.94% 53.60% 7.72% 45.78% 13.55% 13.02%
NOPAT Growth
-6.56% -21.11% -4.40% -79.82% 13.17% 54.13% 9.75% 45.50% 13.00% 8.11%
Net Income Growth
-2.24% -14.86% 8.26% -60.49% 20.15% 61.57% 9.48% 48.40% 15.08% 6.23%
EPS Growth
3.03% -46.75% 11.63% -57.14% 21.88% 27.43% 10.53% 49.09% 16.00% 25.00%
Operating Cash Flow Growth
32.69% 45.31% 32.17% 38.09% 47.18% 92.42% 28.69% -47.94% 39.19% 802.09%
Free Cash Flow Firm Growth
-1,116.92% 0.00% 87.70% 89.76% 93.91% 53.57% 60.70% 1.42% -64.18% -21.26%
Invested Capital Growth
1,892.65% 7.77% 8.43% 4.15% 3.15% 3.38% 1.00% 6.53% 7.13% 4.72%
Revenue Q/Q Growth
8.32% -5.32% 7.41% 5.39% 7.13% 7.75% -4.26% 8.07% 6.87% 4.83%
EBITDA Q/Q Growth
3.65% -92.35% 33.62% 21.79% -75.91% 58.18% -51.87% 19.33% 30.10% 10.77%
EBIT Q/Q Growth
3.70% -79.42% 28.85% -44.81% 51.82% 6.52% -41.49% 14.92% 23.17% 5.95%
NOPAT Q/Q Growth
2.58% -79.87% 27.62% -41.77% 52.96% 4.99% -42.41% 14.38% 24.91% -0.36%
Net Income Q/Q Growth
9.11% -82.55% 33.20% -44.79% 54.78% 12.13% -57.34% 17.47% 25.58% 2.97%
EPS Q/Q Growth
8.57% -606.25% 83.19% -44.74% 54.55% -556.00% 79.27% 17.65% 25.00% -485.71%
Operating Cash Flow Q/Q Growth
-13.86% -50.83% 3.57% 62.61% 2.86% 78.35% -806.80% 22.44% 60.07% 350.00%
Free Cash Flow Firm Q/Q Growth
0.11% 86.68% 5.38% 18.71% 40.60% -1.63% 19.92% -103.92% 1.07% 24.93%
Invested Capital Q/Q Growth
2.28% 0.40% 4.33% -2.78% 1.30% 0.62% 1.93% 2.54% 1.87% -1.65%
Profitability Metrics
- - - - - - - - - -
Gross Margin
39.49% 35.14% 37.38% 39.24% 38.89% 38.30% 39.04% 39.88% 39.40% 39.73%
EBITDA Margin
-12.66% -25.71% -15.89% -11.79% -19.36% -7.52% -11.92% -8.90% -5.82% -4.95%
Operating Margin
-14.68% -27.88% -18.79% -25.27% -11.10% -9.79% -14.55% -11.53% -8.10% -7.76%
EBIT Margin
-14.95% -28.34% -18.77% -25.79% -11.60% -10.06% -14.87% -11.71% -8.42% -7.55%
Profit (Net Income) Margin
-14.52% -28.00% -17.42% -23.93% -10.10% -8.24% -13.53% -10.34% -7.20% -6.66%
Tax Burden Percent
100.00% 102.21% 100.75% 99.75% 101.17% 94.95% 100.00% 99.93% 100.30% 99.59%
Interest Burden Percent
97.11% 96.67% 92.09% 93.00% 86.06% 86.20% 91.01% 88.35% 85.27% 88.60%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-20.94% -23.50% -16.09% -22.66% -10.14% -9.51% -14.23% -11.80% -8.53% -8.53%
ROIC Less NNEP Spread (ROIC-NNEP)
-18.69% -13.38% -8.23% -7.54% -1.70% 0.72% -204.15% -33.18% -18.09% -16.06%
Return on Net Nonoperating Assets (RNNOA)
9.95% 2.76% 1.22% 0.93% 0.15% -0.04% -1.29% -1.41% -1.25% -1.21%
Return on Equity (ROE)
-11.00% -20.73% -14.87% -21.73% -9.98% -9.55% -15.52% -13.21% -9.78% -9.74%
Cash Return on Invested Capital (CROIC)
0.00% -24.53% -24.67% -23.46% -21.73% -18.75% -15.56% -18.31% -18.35% -15.93%
Operating Return on Assets (OROA)
-9.31% -17.46% -10.17% -14.70% -6.91% -6.47% -10.09% -8.48% -6.41% -5.94%
Return on Assets (ROA)
-9.04% -17.25% -9.44% -13.64% -6.02% -5.29% -9.18% -7.49% -5.48% -5.24%
Return on Common Equity (ROCE)
-10.98% -20.68% -14.83% -21.67% -9.95% -9.52% -15.47% -13.16% -9.75% -9.70%
Return on Equity Simple (ROE_SIMPLE)
-19.27% 0.00% -21.42% -25.60% -25.13% 0.00% -20.51% -16.74% -16.20% 0.00%
Net Operating Profit after Tax (NOPAT)
-11 -19 -14 -20 -9.24 -8.78 -12 -11 -8.04 -8.07
NOPAT Margin
-10.27% -19.51% -13.15% -17.69% -7.77% -6.85% -10.19% -8.07% -5.67% -5.43%
Net Nonoperating Expense Percent (NNEP)
-2.25% -10.12% -7.86% -15.12% -8.44% -10.23% 189.92% 21.39% 9.56% 7.53%
Return On Investment Capital (ROIC_SIMPLE)
- -2.94% - - - -1.43% - - - -1.35%
Cost of Revenue to Revenue
60.51% 64.86% 62.62% 60.76% 61.11% 61.70% 60.96% 60.12% 60.60% 60.27%
SG&A Expenses to Revenue
14.60% 15.40% 15.15% 23.05% 12.56% 11.27% 12.16% 12.43% 11.33% 11.77%
R&D to Revenue
7.35% 8.48% 7.71% 8.04% 7.17% 6.94% 7.82% 7.56% 6.59% 6.98%
Operating Expenses to Revenue
54.17% 63.01% 56.16% 64.51% 49.99% 48.09% 53.60% 51.41% 47.50% 47.49%
Earnings before Interest and Taxes (EBIT)
-15 -28 -20 -29 -14 -13 -18 -16 -12 -11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-13 -25 -17 -13 -23 -9.63 -15 -12 -8.25 -7.36
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
6.46 3.89 1.87 2.80 2.29 4.95 2.56 1.69 2.87 6.72
Price to Tangible Book Value (P/TBV)
27.65 19.68 11.29 23.46 21.25 53.24 36.04 27.93 47.07 107.72
Price to Revenue (P/Rev)
7.24 3.79 1.68 2.29 1.77 3.52 1.71 1.06 1.72 3.88
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
7.55 4.27 1.92 2.85 2.28 4.83 2.45 1.61 2.63 6.07
Enterprise Value to Revenue (EV/Rev)
7.05 3.68 1.63 2.27 1.78 3.54 1.76 1.14 1.81 3.95
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.71 0.75 0.77 0.82 0.84 0.85 0.88 0.89 0.90 0.90
Long-Term Debt to Equity
0.71 0.75 0.77 0.82 0.84 0.85 0.88 0.89 0.90 0.90
Financial Leverage
-0.53 -0.21 -0.15 -0.12 -0.09 -0.05 0.01 0.04 0.07 0.08
Leverage Ratio
1.53 1.55 1.92 1.97 1.99 2.05 2.07 2.10 2.11 2.15
Compound Leverage Factor
1.49 1.50 1.77 1.83 1.72 1.77 1.89 1.86 1.80 1.90
Debt to Total Capital
41.56% 42.95% 43.62% 45.06% 45.50% 46.03% 46.74% 47.14% 47.23% 47.33%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
41.56% 42.95% 43.62% 45.06% 45.50% 46.03% 46.74% 47.14% 47.23% 47.33%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.17% 0.17% 0.17% 0.18% 0.18% 0.18% 0.19% 0.19% 0.19% 0.19%
Common Equity to Total Capital
58.28% 56.88% 56.21% 54.77% 54.31% 53.79% 53.07% 52.67% 52.58% 52.48%
Debt to EBITDA
-4.13 -4.01 -4.08 -4.12 -3.60 -4.51 -4.67 -4.78 -6.39 -6.75
Net Debt to EBITDA
0.98 0.63 0.29 0.14 0.00 -0.14 -0.40 -0.64 -1.01 -0.95
Long-Term Debt to EBITDA
-4.13 -4.01 -4.08 -4.12 -3.60 -4.51 -4.67 -4.78 -6.39 -6.75
Debt to NOPAT
-5.52 -5.19 -5.14 -4.44 -4.55 -5.47 -5.63 -6.86 -7.08 -7.22
Net Debt to NOPAT
1.30 0.81 0.37 0.15 -0.01 -0.17 -0.48 -0.91 -1.12 -1.01
Long-Term Debt to NOPAT
-5.52 -5.19 -5.14 -4.44 -4.55 -5.47 -5.63 -6.86 -7.08 -7.22
Altman Z-Score
4.73 2.83 1.58 1.94 1.71 3.02 1.71 1.28 1.92 3.91
Noncontrolling Interest Sharing Ratio
0.15% 0.27% 0.28% 0.30% 0.31% 0.31% 0.33% 0.34% 0.35% 0.35%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
6.30 6.05 5.75 5.28 5.27 4.28 4.34 4.64 4.59 4.38
Quick Ratio
6.03 5.76 5.38 4.98 5.03 4.07 4.10 4.42 4.41 4.20
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-321 -43 -40 -33 -20 -20 -16 -32 -32 -24
Operating Cash Flow to CapEx
-271.19% -424.71% -415.22% -142.87% -167.35% -20.15% -269.93% -210.48% -75.55% 200.24%
Free Cash Flow to Firm to Interest Expense
-268.97 -34.34 -33.79 -27.59 -16.22 -16.72 -13.38 -27.31 -27.04 -20.28
Operating Cash Flow to Interest Expense
-9.48 -13.70 -13.74 -5.16 -4.96 -1.09 -9.87 -7.66 -3.06 7.65
Operating Cash Flow Less CapEx to Interest Expense
-12.97 -16.92 -17.04 -8.77 -7.92 -6.50 -13.52 -11.30 -7.11 3.83
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.62 0.62 0.54 0.57 0.60 0.64 0.68 0.72 0.76 0.79
Accounts Receivable Turnover
9.20 9.32 8.88 8.22 7.55 7.76 7.91 7.81 7.37 7.57
Inventory Turnover
61.62 130.37 137.30 169.40 77.71 127.98 135.66 145.48 132.85 97.03
Fixed Asset Turnover
28.09 25.94 24.23 22.33 20.64 16.94 16.25 15.79 15.44 13.56
Accounts Payable Turnover
25.18 18.68 22.49 19.40 21.24 10.13 22.35 26.82 32.44 8.36
Days Sales Outstanding (DSO)
39.66 39.14 41.11 44.38 48.38 47.01 46.14 46.76 49.53 48.19
Days Inventory Outstanding (DIO)
5.92 2.80 2.66 2.15 4.70 2.85 2.69 2.51 2.75 3.76
Days Payable Outstanding (DPO)
14.49 19.54 16.23 18.81 17.19 36.04 16.33 13.61 11.25 43.65
Cash Conversion Cycle (CCC)
31.09 22.40 27.54 27.73 35.88 13.82 32.49 35.66 41.02 8.31
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
327 328 342 333 337 339 346 355 361 355
Invested Capital Turnover
2.04 1.20 1.22 1.28 1.30 1.39 1.40 1.46 1.50 1.57
Increase / (Decrease) in Invested Capital
311 24 27 13 10 11 3.41 22 24 16
Enterprise Value (EV)
2,467 1,400 656 948 771 1,640 846 572 952 2,155
Market Capitalization
2,532 1,443 675 957 769 1,630 820 533 906 2,114
Book Value per Share
$8.79 $8.28 $8.02 $7.56 $7.41 $7.25 $6.60 $6.85 $6.39 $6.34
Tangible Book Value per Share
$2.05 $1.64 $1.33 $0.90 $0.80 $0.67 $0.47 $0.41 $0.39 $0.40
Total Capital
672 652 643 623 618 612 604 600 600 599
Total Debt
279 280 280 281 281 282 282 283 283 284
Total Long-Term Debt
279 280 280 281 281 282 282 283 283 284
Net Debt
-66 -44 -20 -9.58 0.33 8.88 24 38 45 40
Capital Expenditures (CapEx)
4.17 4.02 3.96 4.31 3.57 6.42 4.35 4.32 4.81 4.54
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3.50 3.79 12 9.63 13 4.26 8.84 16 21 13
Debt-free Net Working Capital (DFNWC)
345 323 308 296 289 273 263 257 255 253
Net Working Capital (NWC)
345 323 308 296 289 273 263 257 255 253
Net Nonoperating Expense (NNE)
4.40 8.32 4.49 6.92 2.77 1.78 4.10 3.00 2.16 1.83
Net Nonoperating Obligations (NNO)
-66 -44 -20 -9.58 0.33 8.88 24 38 45 40
Total Depreciation and Amortization (D&A)
2.38 2.57 3.03 16 -9.24 3.26 3.62 3.72 3.68 3.86
Debt-free, Cash-free Net Working Capital to Revenue
1.00% 0.99% 2.94% 2.30% 2.93% 0.92% 1.84% 3.18% 3.96% 2.37%
Debt-free Net Working Capital to Revenue
98.50% 84.85% 76.51% 70.76% 66.80% 58.92% 54.63% 51.14% 48.52% 46.33%
Net Working Capital to Revenue
98.50% 84.85% 76.51% 70.76% 66.80% 58.92% 54.63% 51.14% 48.52% 46.33%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.32) ($2.26) ($0.38) $0.00 ($0.25) ($1.64) ($0.34) ($0.28) ($0.21) ($1.23)
Adjusted Weighted Average Basic Shares Outstanding
47.30M 94.32M 47.70M 47.87M 47.99M 95.83M 48.58M 48.84M 49.28M 98.17M
Adjusted Diluted Earnings per Share
($0.32) ($2.26) ($0.38) $0.00 ($0.25) ($1.64) ($0.34) ($0.28) ($0.21) ($1.23)
Adjusted Weighted Average Diluted Shares Outstanding
47.30M 94.32M 47.70M 47.87M 47.99M 95.83M 48.58M 48.84M 49.28M 98.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
44.76M 45.07M 45.17M 45.29M 45.39M 48.58M 46.12M 49.30M 49.56M 50.30M
Normalized Net Operating Profit after Tax (NOPAT)
-10 -19 -14 -19 -9.13 -8.78 -12 -11 -8.04 -8.01
Normalized NOPAT Margin
-10.05% -19.24% -13.13% -17.55% -7.68% -6.85% -10.19% -8.07% -5.67% -5.39%
Pre Tax Income Margin
-14.52% -27.39% -17.29% -23.99% -9.98% -8.67% -13.53% -10.34% -7.18% -6.69%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-12.97 -22.30 -16.50 -24.00 -11.45 -10.85 -15.34 -13.07 -10.05 -9.44
NOPAT to Interest Expense
-8.91 -15.36 -11.56 -16.46 -7.67 -7.39 -10.51 -9.01 -6.77 -6.79
EBIT Less CapEx to Interest Expense
-16.47 -25.53 -19.81 -27.61 -14.41 -16.26 -19.00 -16.71 -14.10 -13.26
NOPAT Less CapEx to Interest Expense
-12.40 -18.58 -14.87 -20.07 -10.63 -12.79 -14.17 -12.65 -10.82 -10.61
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Xometry's Financials

When does Xometry's financial year end?

According to the most recent income statement we have on file, Xometry's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xometry's net income changed over the last 5 years?

Xometry's net income appears to be on an upward trend, with a most recent value of -$50.40 million in 2024, rising from -$30.99 million in 2019. The previous period was -$67.47 million in 2023.

What is Xometry's operating income?
Xometry's total operating income in 2024 was -$56.15 million, based on the following breakdown:
  • Total Gross Profit: $215.62 million
  • Total Operating Expenses: $271.77 million
How has Xometry revenue changed over the last 5 years?

Over the last 5 years, Xometry's total revenue changed from $80.23 million in 2019 to $545.53 million in 2024, a change of 580.0%.

How much debt does Xometry have?

Xometry's total liabilities were at $364.53 million at the end of 2024, a 3.3% decrease from 2023, and a 822.9% increase since 2020.

How much cash does Xometry have?

In the past 4 years, Xometry's cash and equivalents has ranged from $22.23 million in 2024 to $86.26 million in 2021, and is currently $22.23 million as of their latest financial filing in 2024.

How has Xometry's book value per share changed over the last 5 years?

Over the last 5 years, Xometry's book value per share changed from 0.00 in 2019 to 6.34 in 2024, a change of 634.4%.



This page (NASDAQ:XMTR) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners